Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
British Journal of Clinical Pharmacology
|
July 10, 2020
Medication use among older people in Europe: Implications for regulatory assessment and co-prescription of new medicines
Anna Strampelli, Francesca Cerreta, Katarina Vučić
Clinical Pharmacology and Therapeutics
|
November 10, 2022
Assessing Medicines for Use in the Geriatric Population
Francesca Cerreta, Katarina Vučić, Andrea Laslop
European Geriatric Medicine
|
October 22, 2021
Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products
Francesca Cerreta, Andreia Padrão, Izabela Skibicka-Stepien, et al.
British Journal of Clinical Pharmacology
|
September 12, 2023
Patient-reported, observer-reported and performance outcomes in qualification procedures at the European Medicines Agency 2013-2018
Marcio Silva, Jane Moseley, Thorsten Vetter, et al.
International Journal of Pharmaceutics
|
May 7, 2016
Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects
Diana A van Riet-Nales, Nasir Hussain, Katarina A E Sundberg, et al.
Digital Biomarkers
|
November 1, 2021
First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases
Laurent Servais, Eric Camino, Aude Clement, et al.
NPJ Digital Medicine
|
March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product development
Seya Colloud, Thomas Metcalfe, Scott Askin, et al.
Clinical Pharmacology and Therapeutics
|
June 15, 2018
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
Hans-Georg Eichler, Nicola Bedlington, Mathieu Boudes, et al.
British Journal of Clinical Pharmacology
|
February 10, 2022
Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population
Diana A van Riet-Nales, Bart van den Bemt, David van Bodegom, et al.
Journal of the American Geriatrics Society
|
May 17, 2024
Medicines for an aging population: The EMA perspective and policies
Francesca Cerreta, Ewa Balkowiec Iskra, Amelia Cupelli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
British Journal of Clinical Pharmacology
|
July 10, 2020
Medication use among older people in Europe: Implications for regulatory assessment and co-prescription of new medicines
Anna Strampelli, Francesca Cerreta, Katarina Vučić
Clinical Pharmacology and Therapeutics
|
November 10, 2022
Assessing Medicines for Use in the Geriatric Population
Francesca Cerreta, Katarina Vučić, Andrea Laslop
European Geriatric Medicine
|
October 22, 2021
Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products
Francesca Cerreta, Andreia Padrão, Izabela Skibicka-Stepien, et al.
British Journal of Clinical Pharmacology
|
September 12, 2023
Patient-reported, observer-reported and performance outcomes in qualification procedures at the European Medicines Agency 2013-2018
Marcio Silva, Jane Moseley, Thorsten Vetter, et al.
International Journal of Pharmaceutics
|
May 7, 2016
Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects
Diana A van Riet-Nales, Nasir Hussain, Katarina A E Sundberg, et al.
Digital Biomarkers
|
November 1, 2021
First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases
Laurent Servais, Eric Camino, Aude Clement, et al.
NPJ Digital Medicine
|
March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product development
Seya Colloud, Thomas Metcalfe, Scott Askin, et al.
Clinical Pharmacology and Therapeutics
|
June 15, 2018
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
Hans-Georg Eichler, Nicola Bedlington, Mathieu Boudes, et al.
British Journal of Clinical Pharmacology
|
February 10, 2022
Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population
Diana A van Riet-Nales, Bart van den Bemt, David van Bodegom, et al.
Journal of the American Geriatrics Society
|
May 17, 2024
Medicines for an aging population: The EMA perspective and policies
Francesca Cerreta, Ewa Balkowiec Iskra, Amelia Cupelli, et al.
Page
of 2